Sign inJoin waitlistJoin the waitlist

Cathy Eng

VICC Director of Strategic Relations and Research Partnerships · Vanderbilt University Medical Center

Credentials: · · · · · ·

History

Vanderbilt University Medical Center
Present
Vanderbilt University Medical Center
Present

Hematology and Medical Oncology
University of Chicago Medical Center
1999–2002
Internal Medicine
Rush University Medical Center
1996–1997
Cooperman Barnabas Medical Center
1995–1996
Hahnamann Honoeopathic Medical College
1994–1995
Vanderbilt University School of Medicine
1990–1994

Research

Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
Journal of Clinical Oncology · 2009 · 1,031 citations
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
Journal of Clinical Oncology · 2006 · 999 citations
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases
Annals of Surgery · 2005 · 860 citations

Scott Kopetz
62 papers · 1 as a fellow
Michael Overman
56 papers · 4 as a fellow
Robert Wolff
49 papers
George Chang
47 papers
Prajnan Das
46 papers
Van Morris
46 papers · 5 as a fellow
Miguel Rodriguez-Bigas
42 papers
JS
John Skibber
40 papers
Christopher Crane
36 papers
Arvind Dasari
30 papers
Sunil Krishnan
29 papers
Kanwal Raghav
28 papers · 1 as a fellow

Grants

Cultivating Programmatic Efforts to Optimize the Conduct and Implementation of NCI-Funded Clinical Trials
National Cancer Institute · R50
Contact PI · $391.3K · Vanderbilt University Medical Center
2024–2029
Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $89.4K · Vanderbilt University Medical Center
1998–2025
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
National Cancer Institute · U10
Contact PI · $4.4M · University of Tx Md Anderson Can Ctr
2014–2019
U10 Full Member Application Affiliated with SWOG
National Cancer Institute · U10
Contact PI · $682.4K · University of Tx Md Anderson Can Ctr
2004–2015

Clinical trials

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients
Principal investigator · Active not recruiting · Phase 3
National Cancer Institute (NCI)
2020–2027
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2015–2027
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2013–2019
AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)
2006–2011